Update on adjuvant treatment in HER2+ BC.

ABSTRACT

Text generated by AI based on an exclusive interview, revised and reviewed by

Joseph GLIGOROV
MD, PHD Medical Oncologist, Paris, France

Molecular profiling of breast cancers.
Frédérique PENAULT-LLORCA
Pathologist, Clermont Ferrand, France
Molecular profiling of breast cancers.
Benjamin VERRET
Oncologist, Villejuif, France
What are the key findins of the PATINA trial for patients with hormone receptor-positive, HER2-positive metastatic breast cancer ?
Hassan GHAZAL
oncologist, Dubai
Overview in High Risk Patient Screening
Dana Haddad

MD, PhD, American Board Certified consultant breast radiologist

and Head of Breast Imaging at Healthbay Polyclinic in Dubai, UAE
What are the limitation of mammography?
Dana HADDAD
radiologist, UAE